Titel

Merkliste
1 Ergebnisse

Kaplan Meier cumulative incidence curves for SARS-CoV-2 bre..:

Alfred Jerrod Anzalone (14334078) ; Jing Sun (141206) ; Amanda J. Vinson (6856904)...
https://figshare.com/articles/figure/Kaplan_Meier_cumulative_incidence_curves_for_SARS-CoV-2_breakthrough_infection_following_two_mRNA_vaccinations_in_adults_January_1_2021_December_20_2021_/21823167. , 2023

Link: https://doi.org/10.1371/journal.pone.0279968.g002

RT Journal
T1 <Title>Kaplan Meier cumulative incidence curves for SARS-CoV-2 breakthrough infection following two mRNA vaccinations in adults, January 1, 2021 –December 20, 2021</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivfreestate:oai:figshare.com:article_21823167&Exemplar=1&LAN=DE
				
A1 Alfred Jerrod Anzalone (14334078)
A1 Jing Sun (141206)
A1 Amanda J. Vinson (6856904)
A1 William H. Beasley (12982962)
A1 William B. Hillegass (13771761)
A1 Kimberly Murray (11964635)
A1 Brian M. Hendricks (14334081)
A1 Melissa Haendel (14045)
A1 Carol Reynolds Geary (14334084)
A1 Kristina L. Bailey (14334087)
A1 Corrine K. Hanson (14334090)
A1 Lucio Miele (81383)
A1 Ronald Horswell (308940)
A1 Julie A. McMurry (4182448)
A1 J. Zachary Porterfield (6904217)
A1 Michael T. Vest (14334093)
A1 H. Timothy Bunnell (14334096)
A1 Jeremy R. Harper (14334099)
A1 Bradley S. Price (6441476)
A1 Susan L. Santangelo (14334102)
A1 Clifford J. Rosen (9562982)
A1 James C. McClay (14334105)
A1 Sally L. Hodder (11642878)
YR 2023
K1 Medicine
K1 Biotechnology
K1 Immunology
K1 Cancer
K1 Science Policy
K1 Infectious Diseases
K1 Virology
K1 Computational Biology
K1 us adults sampled
K1 adjusted hazard ratio
K1 42 &# 8211
K1 27 &# 8211
K1 23 &# 8211
K1 02 &# 8211
K1 county vaccination rates
K1 adverse events across
K1 retrospective cohort study
K1 19 events based
K1 county vaccine hesitancy
K1 low vaccination rates
K1 adverse breakthrough events
K1 significantly lower odds
K1 95 &# 8211
K1 high vaccination rates
K1 among vaccinated persons
K1 medium vaccination rates
K1 high vaccine hesitancy
K1 low vaccine
K1 vaccinated persons
K1 documented vaccination
K1 study period
K1 breakthrough infections
K1 19 vaccinations
K1 compromised persons
K1 128 vaccinated
K1 vaccination sars
K1 adverse covid
K1 xlink ">
K1 using kaplan
K1 targeted interventions
K1 september 21
K1 secondarily assessed
K1 n3c )
K1 including immunosuppressed
K1 higher risks
K1 higher odds
K1 high risk
K1 geographic areas
K1 findings suggest
K1 demographic differences
JF https://figshare.com/articles/figure/Kaplan_Meier_cumulative_incidence_curves_for_SARS-CoV-2_breakthrough_infection_following_two_mRNA_vaccinations_in_adults_January_1_2021_December_20_2021_/21823167
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0279968.g002
DO https://doi.org/10.1371/journal.pone.0279968.g002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)